Dear all,
Please be aware of two open positions for modelling scientists at Novo Nordisk,
located in the Copenhagen area, Denmark. Both positions will be within our CMC
area focusing on creating links between formulation/process development
activities and pharmacokinetic properties in animals and humans
1. Injectables:
The candidate will be involved with establishing mathematical models describing
how protein association affects pharmacokinetics of injectable diabetes
products, and to predict how it will be influenced by formulation and process
changes.
We are looking for a person who can fill in this position, and we would be
grateful if you could consider if this could be of interest to you or persons
in your network.
The job posting can be found here:
http://www.novonordisk.com/careers/see-list-of-all-available-jobs.33210BR.Internal.html
2. Oral products:
The candidate will focus on establishing in-vitro in-vivo correlations (IVIVC)
for our new range of oral diabetes products, which can be used to predict how
pharmacokinetics will be influenced by formulation and process changes, based
on in-vitro measurements of the drug product.
We are looking for a person who can fill in this position, and we would be
grateful if you could consider if this could be of interest to you or persons
in your network.
The job posting can be found here:
http://www.novonordisk.com/careers/see-list-of-all-available-jobs.33196BR.Internal.html.
For further information regarding the two positions, please contact Rosa
Rebecca Erritzøe Hansen at +45 3075 5657, Thorbjørn Strøm-Hansen at +45 3079
1275 or Karina Sinding Thorsøe at +45 3075 6278.
Applications must be submitted online via the two links above.
Kind regards
Steen
____________________________________
Steen Hvass Ingwersen
Principal Modelling Scientist
Quantitative Clinical Pharmacology
Novo Nordisk A/S
Vandtårnsvej 108-110
DK-2860 Søborg
Denmark
+45 4444 8888 (phone)
+45 3079 4847 (mobile)
[email protected]
http://www.facebook.com/novonordisk |
http://www.twitter.com/novonordisk |
http://www.linkedin.com/company/novo-nordisk |
http://www.Youtube.com/novonordisk |
http://www.pinterest.com/novonordisk
Changing diabetes since 1923
Did you know that Novo Nordisk was the first company to introduce insulin to
Scandinavia? Find out more
http://www.novonordisk.com/about_us/history/novo-nordisk-history.asp
This e-mail (including any attachments) is intended for the addressee(s) stated
above only and may contain confidential information protected by law. You are
hereby notified that any unauthorized reading, disclosure, copying or
distribution of this e-mail or use of information contained herein is strictly
prohibited and may violate rights to proprietary information. If you are not an
intended recipient, please return this e-mail to the sender and delete it
immediately hereafter. Thank you.